We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Male Partner Involvement in the Prevention of MTCT of HIV

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00405990
First Posted: December 4, 2006
Last Update Posted: May 29, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
University of Cape Town
Information provided by:
Imperial College London
  Purpose
The study aims to invite male sexual partners to attend antenatal clinic with their pregnant partners to either acquire pregnancy information or undergo voluntary counselling and testing for HIV. To see if male sexual partner involvement will decrease sexual risk behaviour.

Condition Intervention Phase
HIV Infections Behavioral: Voluntary counselling and HIV testing in ANC for PMTCT Behavioral: VCT Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Screening
Official Title: Optimizing the Impact of Prevention of Mother to Child Transmission of HIV in South Africa: the Forgotten Half of the Equation.

Resource links provided by NLM:


Further study details as provided by Imperial College London:

Primary Outcome Measures:
  • Percentage of partners agreeing to attend VCT. [ Time Frame: 12 weeks ]

Secondary Outcome Measures:
  • Percentage of partners and pregnant women abstaining, faithful to one partner and using condoms consistently. [ Time Frame: 12 weeks ]

Estimated Enrollment: 1000
Study Start Date: November 2006
Study Completion Date: May 2008
Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Voluntary counselling and HIV testing in ANC for PMTCT
    VCT for 30 minutes in ANC
    Other Names:
    • ANC VCT
    • VCT for PMTCT
    Behavioral: VCT
    HIV VCT for PMTCT
    Other Name: VCT for PMTCT
Detailed Description:

We will enrol 1000 pregnant women; recruited from antenatal clinic at Khayelitsha Midwive and Obstetric Unit (MOU). Community sensitization activities will be implemented in the catchment community to encourage male partner participation.

At the booking visit all women will be offered antenatal care, HIV group education and VCT as usual. Thereafter women will be recruited to enrol into the study, after signing the consent form half of the cohort members will be randomly assigned to partner VCT (Group A) and half to partner pregnancy information (Group B). Men in group B will be offered VCT at the second interview late in pregnancy. However, VCT will be provided if requested by study participants at any stage of the study or if the female partner is HIV positive. Women in group A will be given a written invitation to hand to their partners to encourage them to invite their partners to come to the antenatal clinic for VCT. In group B, women will be given a written invitation to give to their partners to encourage their partners to attend a pregnancy information session at the antenatal clinic.

VCT will be offered again close to delivery for all women and men who were previously uninfected or of unknown status. For those found to be HIV-infected at a prior visit, CD4 and CD8 T-cell counts, viral load, and full blood count tests will be conducted. Both women and men will be referred to the Antiretroviral clinic where ARV will be offered if appropriate and formula feeding (or exclusive breastfeeding) will be recommended. Reasons for declining VCT and data on sexual behaviour and violence will be sought at each visit.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • To be eligible for participation, a woman must be less than 30 weeks pregnant at enrolment.

Exclusion Criteria:

  • Women who are more than 30 weeks pregnant will be excluded.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00405990


Locations
South Africa
Khayelitsha Midwive and Obstetric Unit Site B
Cape Town, Western Cape, South Africa, 7784
Sponsors and Collaborators
Imperial College London
University of Cape Town
Investigators
Principal Investigator: Boshishi K Mohlala, MBCHB FCOG MSC Imperial College London
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00405990     History of Changes
Other Study ID Numbers: cro625
First Submitted: November 30, 2006
First Posted: December 4, 2006
Last Update Posted: May 29, 2015
Last Verified: May 2008

Keywords provided by Imperial College London:
HIV
MTCT
heterosexual behaviour
sexual risk behaviour
couple counselling
Voluntary counselling and testing
HIV Seronegativity

Additional relevant MeSH terms:
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases